Shares in pharmaceutical and biotech companies fell last night after US President-Elect Donald Trump revealed plans to force the industry to bid on government business during his first press conference since the election.
Speaking yesterday, Trump accused pharmaceutical companies of "getting away with murder" over the high costs of drugs in the US and their use of overseas locations for drug production, according to Bloomberg. The President-Elect said: "We have got to get our drug industry back. Our drug industry has been disastrous. They are leaving left and right. They supply our drugs but they do not make them here, to a large extent. "And the other thing we have to do is create new bidding procedures for the drug industry because they are getting away with murder." How could a new president imp...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
